This is an academic overview derived from the Wikipedia article on Monoamine Oxidase. Read the full source article here. (opens in new tab)

MAO Unveiled

An exploration of Monoamine Oxidase (MAO), the critical enzymes involved in neurotransmitter metabolism and their profound implications in neurological and psychiatric health.

What is MAO? ๐Ÿ‘‡ Clinical Relevance โš•๏ธ

Dive in with Flashcard Learning!


When you are ready...
๐ŸŽฎ Play the Wiki2Web Clarity Challenge Game๐ŸŽฎ

Defining Monoamine Oxidase

Enzymatic Function

Monoamine oxidases (MAOs), classified under EC 1.4.3.4, are a family of enzymes responsible for catalyzing the oxidative deamination of monoamines. This process involves the oxidation of monoamines, utilizing oxygen to cleave the amine group. They are integral components of the flavin-containing amine oxidoreductase protein family.

Cellular Localization

MAOs are primarily located on the outer mitochondrial membrane in most cell types throughout the body. This strategic positioning allows them to efficiently metabolize monoamines, both those ingested through diet and endogenous neurotransmitters.

Historical Context

The first MAO enzyme was identified in 1928 by Mary Bernheim in liver tissue and was initially named tyramine oxidase. Its discovery marked a significant step in understanding metabolic pathways involving amines.

Identification

Key identifiers for Monoamine Oxidase include:

IdentifierValue
EC Number1.4.3.4
CAS Number9001-66-5
PfamPF01593
InterProIPR001613

MAO Subtypes and Distribution

MAO-A

Monoamine oxidase A (MAO-A) is predominantly involved in the catabolism of neurotransmitters such as serotonin, norepinephrine, and epinephrine. It is expressed in neurons and glia, as well as in the liver, pulmonary vascular endothelium, gastrointestinal tract, and placenta. MAO-A levels reach adult concentrations shortly after birth.

MAO-B

Monoamine oxidase B (MAO-B) primarily metabolizes phenethylamine and benzylamine. While also found in neurons and glia, it is predominantly localized in blood platelets outside the central nervous system. MAO-B activity increases with age, particularly in the brain and pineal gland.

Tissue Distribution

Both MAO-A and MAO-B exhibit distinct regional distributions within the brain. High levels of both are found in the hypothalamus and hippocampal uncus. The striatum and globus pallidus show high MAO-B activity with minimal MAO-A, whereas the cortex has higher MAO-A levels, with exceptions in the cingulate cortex.

Mechanism of Action

Oxidative Deamination

MAOs catalyze oxidative deamination. The process begins with the oxidation of the substrate by the flavin adenine dinucleotide (FAD) cofactor, generating a reduced FADH2 form. The resulting imine intermediate is then hydrolyzed non-enzymatically into an aldehyde and ammonia. Molecular oxygen is required to regenerate the active FAD cofactor.

Structural Homology

MAO-A and MAO-B share approximately 70% structural similarity. Their substrate binding sites are largely hydrophobic. Key tyrosine residues within these sites are hypothesized to play a role in substrate orientation and inhibitor interactions, potentially linking to mental health conditions.

Novel Roles of MAO-B

Recent findings suggest MAO-B's role extends beyond neurotransmitter breakdown. In rodents, MAO-B participates in striatal GABA synthesis from putrescine, influencing dopaminergic neuron activity. This pathway, mediated by MAO-B in astrocytes, is observed across various brain regions and may necessitate a re-evaluation of MAO-B inhibitor therapies for conditions like Parkinson's disease.

Substrates and Specificities

MAO-A Substrates

MAO-A preferentially catabolizes:

  • Serotonin
  • Norepinephrine
  • Epinephrine
  • Tryptamine
  • Tyramine
  • Dopamine

MAO-A inhibitors are primarily used as antidepressants and anti-anxiety agents.

MAO-B Substrates

MAO-B preferentially catabolizes:

  • Phenethylamine
  • Benzylamine
  • Tryptamine
  • Tyramine
  • Dopamine

MAO-B inhibitors are utilized in managing Parkinson's disease and Alzheimer's disease.

Exogenous Compounds

Beyond endogenous monoamines, MAOs metabolize numerous exogenous compounds and drugs. These include various sympathomimetics, sympatholytics, serotonergic agents (e.g., DMT, sumatriptan), and other pharmaceuticals like citalopram, nomifensine, and sertraline. Some drugs, like haloperidol, may form neurotoxic metabolites via MAO activity.

Clinical Significance

MAO Activity and Disease

Dysregulation of MAO activity (either excessive or deficient) is implicated in various psychiatric and neurological disorders. Altered MAO levels have been associated with schizophrenia, depression, attention deficit disorders, substance abuse, and migraines. MAO-A inhibitors are prescribed for depression, while MAO-B inhibitors are used for neurodegenerative diseases.

MAOI Interactions

Monoamine oxidase inhibitors (MAOIs) require careful management due to potential interactions. Excessive levels of catecholamines (epinephrine, norepinephrine, dopamine) can precipitate a hypertensive crisis, while excessive serotonin can lead to serotonin syndrome. Dietary restrictions (avoiding tyramine-rich foods) are crucial when using MAO-A inhibitors.

Parasites and Insects

MAO activity is relevant in host-parasite interactions. For instance, trypanosomes causing sleeping sickness disrupt MAO activity in the orexin system, affecting sleep patterns. Furthermore, certain insecticides function by inhibiting insect MAOs, highlighting the enzyme's conserved biological importance.

Genetic Basis of MAO

Gene Location and Polymorphisms

The genes encoding MAO-A and MAO-B are located adjacently on the X chromosome (Xp11.4-p11.3). They exhibit significant sequence similarity. Rare mutations in the MAO-A gene are linked to Brunner syndrome. Promoter region polymorphisms, particularly the low-activity variant of MAO-A, have been studied in relation to antisocial behavior, although findings suggest environmental factors (maltreatment) play a more significant role, and genetic predisposition may be inherited alongside abusive environments.

Behavior and Genetics

Research suggests a potential link between MAO-A gene variants and personality traits like novelty seeking. Variations in MAO-A gene frequencies exist across different ethnic groups. The popular press has termed certain variants the "warrior gene," though this requires careful interpretation due to the complex interplay of genetics and environment.

MAO Activity and Aging

Age-Related Changes

Unlike many enzymes, MAO-B activity demonstrates an increase with age in mammalian brains, including humans. This phenomenon is also observed in the pineal gland of aging rats. The elevated MAO-B activity may contribute to reduced monoamine levels observed in the aged brain and pineal gland.

Teacher's Corner

Edit and Print this course in the Wiki2Web Teacher Studio

Edit and Print Materials from this study in the wiki2web studio
Click here to open the "Monoamine Oxidase" Wiki2Web Studio curriculum kit

Use the free Wiki2web Studio to generate printable flashcards, worksheets, exams, and export your materials as a web page or an interactive game.

True or False?

Test Your Knowledge!

Gamer's Corner

Are you ready for the Wiki2Web Clarity Challenge?

Learn about monoamine_oxidase while playing the wiki2web Clarity Challenge game.
Unlock the mystery image and prove your knowledge by earning trophies. This simple game is addictively fun and is a great way to learn!

Play now

Explore More Topics

Discover other topics to study!

                                        

References

References

A full list of references for this article are available at the Monoamine oxidase Wikipedia page

Feedback & Support

To report an issue with this page, or to find out ways to support the mission, please click here.

Academic Disclaimer

Important Notice

This document was generated by an AI acting as a Professional PhD Professor, synthesizing information from publicly available data sources. It is intended strictly for academic and educational purposes at a postgraduate level.

This is not medical advice. The content herein should not substitute for professional medical consultation, diagnosis, or treatment. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment. Reliance on any information provided in this document is solely at your own risk.

The creators of this content are not liable for any errors, omissions, or actions taken based on the information presented. Ensure verification against primary sources and consult with experts for critical applications.